{"disease":{"id":"primary-sj-gren-s-syndrome","name":"primary sj gren s syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06982482","title":"Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":27432,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT05673993","title":"A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"RemeGen Co., Ltd.","has_results":false},{"nct_id":"NCT05113004","title":"New Clinical End-points in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04212572","title":"Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":242,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04544722","title":"Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":138,"lead_sponsor_name":"Shanghai University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04186871","title":"Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04684654","title":"BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":118,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT01782235","title":"Efficacy of Tocilizumab in Primary Sjögren's Syndrome.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT07145060","title":"A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT04975087","title":"The Profile of Fatigue and Discomfort - Sicca Symptoms Inventory","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT03681964","title":"Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04858464","title":"Reliability, Validity of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT02291029","title":"Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06432101","title":"Acupuncture Combined With Hydroxychloroquine","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Senyue Zhang","has_results":false},{"nct_id":"NCT02464319","title":"A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04605978","title":"Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Institut de Recherches Internationales Servier","has_results":true},{"nct_id":"NCT06947473","title":"Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Beijing GoBroad Hospital","has_results":false},{"nct_id":"NCT06947460","title":"CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Beijing GoBroad Hospital","has_results":false},{"nct_id":"NCT04078386","title":"A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"RemeGen Co., Ltd.","has_results":false},{"nct_id":"NCT06989411","title":"Current Therapy in Primary Sjogren's Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT05817669","title":"A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"argenx","has_results":true},{"nct_id":"NCT02334306","title":"A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"MedImmune LLC","has_results":true},{"nct_id":"NCT06862284","title":"Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06484855","title":"Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT02775916","title":"Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05269810","title":"Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Samjin Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02149420","title":"PD of VAY736 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03700138","title":"Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06203457","title":"Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"argenx","has_results":true},{"nct_id":"NCT07184450","title":"Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":11,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03627065","title":"A Study of INCB050465 in Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT05087589","title":"Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06967038","title":"Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Bangdong Gong","has_results":false},{"nct_id":"NCT05781451","title":"Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT07244289","title":"Managed Access Programs for VAY736, Ianalumab","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}